Montserrat Mestre1, Judith Lleberia1, Josep Pubill1, Montserrat Espuña-Pons2. 1. Pelvic Floor Unit, Department of Obstetrics and Gynecology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí, I3PT, Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain. 2. Pelvic Floor Unit, ICGON, Hospital Clínic de Barcelona, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain. mespuna@clinic.ub.es.
Abstract
INTRODUCTION AND HYPOTHESIS: The aim of this study was to transculturally adapt the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire IUGA-Revised (PISQ-IR) into Spanish and to validate the new version. METHODS: We carried out a two-stage observational cross-sectional study: translation and back-translation, followed by a validation stage in which the final version was administered to 268 consecutive women (118 not sexually active [NSA] and 150 sexually active [SA]) older than 18 from an Urogynecology Unit. Besides PISQ-IR, women also completed the following questionnaires: Incontinence Severity Index (ISI); Female Sexual Function Index (FSFI); Pelvic Floor Distress Inventory (PFDI-20); and question #35 from the Epidemiology of Prolapse and Incontinence Questionnaire (EPIQ). Feasibility (percentage of valid cases), internal consistency (Cronbach's alpha), and construct validity (structural, by factor analysis, and convergent validity by Spearman's Rho) were evaluated. RESULTS: The sample was formed by 118 NSA and 150 SA women, with a mean age (SD) of 59.2 (11.5) years; mean body mass index (BMI) of 29.6 kg/m2 (5.6), and mean parity of 2.6 deliveries (1.2). PISQ-IR showed a high response rate (98.3% NSA and 94.7% SA), and elevated internal consistency (Cronbach's alpha for NSA and SA of 0.79 and 0.91 respectively). Factor analysis confirmed the structure of the original questionnaire and the convergent validity showed moderate to strong correlation between PISQ-IR and the ISI, PFDI-20, and FSFI scores, in addition to item #35 of the EPIQ. CONCLUSIONS: The Spanish version of the PISQ-IR has adequate psychometric properties; therefore, it can be a useful tool for assessing sexual function in women with pelvic floor disorders.
INTRODUCTION AND HYPOTHESIS: The aim of this study was to transculturally adapt the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire IUGA-Revised (PISQ-IR) into Spanish and to validate the new version. METHODS: We carried out a two-stage observational cross-sectional study: translation and back-translation, followed by a validation stage in which the final version was administered to 268 consecutive women (118 not sexually active [NSA] and 150 sexually active [SA]) older than 18 from an Urogynecology Unit. Besides PISQ-IR, women also completed the following questionnaires: Incontinence Severity Index (ISI); Female Sexual Function Index (FSFI); Pelvic Floor Distress Inventory (PFDI-20); and question #35 from the Epidemiology of Prolapse and Incontinence Questionnaire (EPIQ). Feasibility (percentage of valid cases), internal consistency (Cronbach's alpha), and construct validity (structural, by factor analysis, and convergent validity by Spearman's Rho) were evaluated. RESULTS: The sample was formed by 118 NSA and 150 SAwomen, with a mean age (SD) of 59.2 (11.5) years; mean body mass index (BMI) of 29.6 kg/m2 (5.6), and mean parity of 2.6 deliveries (1.2). PISQ-IR showed a high response rate (98.3% NSA and 94.7% SA), and elevated internal consistency (Cronbach's alpha for NSA and SA of 0.79 and 0.91 respectively). Factor analysis confirmed the structure of the original questionnaire and the convergent validity showed moderate to strong correlation between PISQ-IR and the ISI, PFDI-20, and FSFI scores, in addition to item #35 of the EPIQ. CONCLUSIONS: The Spanish version of the PISQ-IR has adequate psychometric properties; therefore, it can be a useful tool for assessing sexual function in women with pelvic floor disorders.
Entities:
Keywords:
Pelvic floor disorders; Questionnaire; Sexual function assessment; Spanish validation
Authors: R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith Journal: Am J Obstet Gynecol Date: 1996-07 Impact factor: 8.661
Authors: Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer Journal: Int Urogynecol J Date: 2009-11-25 Impact factor: 2.894
Authors: R G Rogers; T H Rockwood; M L Constantine; R Thakar; D N Kammerer-Doak; R N Pauls; M Parekh; B Ridgeway; S Jha; J Pitkin; F Reid; S E Sutherland; E S Lukacz; C Domoney; P Sand; G W Davila; M E Espuna Pons Journal: Int Urogynecol J Date: 2013-04-30 Impact factor: 2.894
Authors: Gerda Trutnovsky; Eva Nagele; Daniela Ulrich; Thomas Aigmüller; Daniela Dörfler; Ingrid Geiss; Evi Reinstadler; Johannes Angleitner-Flotzinger; Jean-Jacques Ries; Vesna Bjelic-Radisic Journal: Int Urogynecol J Date: 2016-02-16 Impact factor: 2.894
Authors: Marina Guallar-Bouloc; Paloma Gómez-Bueno; Manuel Gonzalez-Sanchez; Guadalupe Molina-Torres; Rafael Lomas-Vega; Alejandro Galán-Mercant Journal: Int J Environ Res Public Health Date: 2021-12-06 Impact factor: 3.390